These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17053366)

  • 1. Atazanavir urinary stones in an HIV-infected patient.
    Pacanowski J; Poirier JM; Petit I; Meynard JL; Girard PM
    AIDS; 2006 Oct; 20(16):2131. PubMed ID: 17053366
    [No Abstract]   [Full Text] [Related]  

  • 2. Atazanavir-containing renal calculi in an HIV-infected patient.
    Anderson PL; Lichtenstein KA; Gerig NE; Kiser JJ; Bushman LR
    AIDS; 2007 May; 21(8):1060-2. PubMed ID: 17457108
    [No Abstract]   [Full Text] [Related]  

  • 3. Disappearance of renal stones in an HIV-1-infected patient after reduction of atazanavir dose.
    Lanzafame M; Bonora S; Lattuada E; Calcagno A; Di Perri G; Concia E
    AIDS Res Hum Retroviruses; 2014 Sep; 30(9):835-6. PubMed ID: 24998758
    [No Abstract]   [Full Text] [Related]  

  • 4. Atazanavir crystal nephropathy.
    Izzedine H; M'rad MB; Bardier A; Daudon M; Salmon D
    AIDS; 2007 Nov; 21(17):2357-8. PubMed ID: 18090291
    [No Abstract]   [Full Text] [Related]  

  • 5. Atazanavir urolithiasis.
    Chang HR; Pella PM
    N Engl J Med; 2006 Nov; 355(20):2158-9. PubMed ID: 17108352
    [No Abstract]   [Full Text] [Related]  

  • 6. Urolithiasis in HIV-positive patients treated with atazanavir.
    Couzigou C; Daudon M; Meynard JL; Borsa-Lebas F; Higueret D; Escaut L; Zucman D; Liotier JY; Quencez JL; Asselah K; May T; Neau D; Vittecoq D
    Clin Infect Dis; 2007 Oct; 45(8):e105-8. PubMed ID: 17879904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rash in an HIV-positive patient.
    Herzmann C; Kinloch S; Johnson M
    HIV Med; 2005 Nov; 6(6):379. PubMed ID: 16268818
    [No Abstract]   [Full Text] [Related]  

  • 8. Atazanavir-associated menorrhagia.
    Paparizos VA; Kourkounti S; Leuow K; Kyriakis KP; Botsi C; Katsambas AD
    Int J STD AIDS; 2007 Sep; 18(9):651-2. PubMed ID: 17785018
    [No Abstract]   [Full Text] [Related]  

  • 9. [Simplified HIV therapy. Atazanavir: the first protease inhibitor with once daily administration].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():14-6. PubMed ID: 15373035
    [No Abstract]   [Full Text] [Related]  

  • 10. Atazanavir-associated choledocholithiasis leading to acute hepatitis in an HIV-infected adult.
    Jacques AC; Giguère P; Zhang G; Touchie C; la Porte CJ
    Ann Pharmacother; 2010 Jan; 44(1):202-6. PubMed ID: 19955297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of renal stones in patients treated with atazanavir.
    Tattevin P; Revest M; Chapplain JM; Ratajczak-Enselme M; Arvieux C; Michelet C
    Clin Infect Dis; 2013 Apr; 56(8):1186. PubMed ID: 23300244
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic interstitial nephritis in an HIV type-1-infected patient receiving ritonavir-boosted atazanavir.
    Viglietti D; Verine J; De Castro N; Scemla A; Daudon M; Glotz D; Pillebout E
    Antivir Ther; 2011; 16(1):119-21. PubMed ID: 21311116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alopecia associated with ritonavir-boosted atazanavir therapy.
    Torres HA; Barnett BJ; Arduino RC
    AIDS; 2007 Jun; 21(10):1391-2. PubMed ID: 17545728
    [No Abstract]   [Full Text] [Related]  

  • 14. Case presentation: nephrolithiasis in a patient treated with atazanavir.
    Savini C; James C; Wilson S; Martin H; Szabo S; Scotto V
    J Assoc Nurses AIDS Care; 2008; 19(3):225-7. PubMed ID: 18457764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ritonavir-boosted atazanavir, methadone, and ventricular tachycardia: 2 case reports.
    Gallagher DP; Kieran J; Sheehan G; Lambert J; Mahon N; Mallon PW
    Clin Infect Dis; 2008 Aug; 47(3):e36-8. PubMed ID: 18558878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrocardiographic changes in HIV-infected, drug-experienced patients being treated with atazanavir.
    Gianotti N; Guffanti M; Galli L; Margonato A; Chiaravalli G; Bigoloni A; Lazzarin A; Castagna A
    AIDS; 2007 Jul; 21(12):1648-51. PubMed ID: 17630564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HIV agents. Atazanavir and raltegravir--an interesting combination.
    TreatmentUpdate; 2009; 21(3):3-4. PubMed ID: 19623725
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen.
    Colafigli M; Di Giambenedetto S; Bracciale L; Tamburrini E; Cauda R; De Luca A
    HIV Med; 2008 Mar; 9(3):172-9. PubMed ID: 18217998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-HIV agents. Atazanavir and saquinavir.
    TreatmentUpdate; 2004; 16(3):9-10. PubMed ID: 17219610
    [No Abstract]   [Full Text] [Related]  

  • 20. Does atazanavir cause lipodystrophy?
    Gazzard BG; Moyle G
    J HIV Ther; 2004 May; 9(2):41-4. PubMed ID: 15238875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.